The effect of phthalates on the heart: molecular pathways and clinical relevance

邻苯二甲酸盐对心脏的影响:分子途径和临床相关性

基本信息

  • 批准号:
    8402828
  • 负责人:
  • 金额:
    $ 4.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-01-01 至 2013-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Di(2-ethylhexyl) phthalate (DEHP) is used in a variety of medical products, as it allows stiff plastics, such as polyvinyl chloride, to become more flexible. DEHP is commonly found in medical devices, including intravenous bags and tubing that are used for various procedures. DEHP is highly hydrophobic, and as a result, it leaches from plastics when in contact with blood, serum, and other lipophilic fluids. Since a number of animal studies have reported toxic effects of DEHP, phthalate leaching is a source of concern for human health. The majority of previous studies focused on DEHP carcinogenicity and its adverse effects on reproductive health. Indeed, the risk of testicular toxicity was found to be substantial enough to warrant the use of DEHP-free plastics for premature boys. In contrast, little is known about the adverse effects of DEHP on the heart, and awareness of its potential cardiotoxicity is essentially non-existent. When clinically relevant concentrations of DEHP were applied to monolayers of rat neonatal cardiomyocytes, treatment markedly impaired conduction velocity and diminished the amount of connexin-43. DEHP treatment also affected the adhesion and motion of the cell layers. The main goals of the proposed studies are to confirm and understand the mechanism behind DEHP's effect on cardiac muscle and to establish its clinical relevance. Aim 1 of the proposal is to dissect the molecular pathways affected by DEHP that leads to cardiac electrical uncoupling using genomics and computational strategies. Clinically relevant concentrations of DEHP will be delivered parenterally via implantable osmotic pumps. Ventricular cardiac tissue will be collected and modifications in gene expression will be assessed. Key candidate genes will be further investigated using functional validation assays. Aim 2 of the proposal is to determine if in vivo exposure to DEHP leads to cardiac dysfunction. DEHP will be delivered parenterally via implantable osmotic pumps. Echocardiography will be conducted to assess contractility in vivo, both before and after DEHP treatment. Optical mapping of excised hearts will measure changes in local conduction velocities, calcium transients and calcium handling.
描述(由申请人提供):邻苯二甲酸二(2-乙基己基)酯(DEHP)用于各种医疗产品,因为它可以使硬质塑料(如聚氯乙烯)变得更灵活。DEHP通常存在于医疗设备中,包括用于各种程序的静脉注射袋和管。DEHP是高度疏水性的,因此,当与血液、血清和其他亲脂液体接触时,它会从塑料中滤出。由于许多动物研究报告了DEHP的毒性作用,邻苯二甲酸盐浸出是人类健康关注的一个来源。以往的研究大多集中在DEHP致癌性及其对生殖健康的不利影响上。事实上,睾丸毒性的风险被发现是相当大的,足以保证对早产儿使用不含dehp的塑料。相比之下,DEHP对心脏的不良影响知之甚少,对其潜在心脏毒性的认识基本上是不存在的。当将临床相关浓度的DEHP应用于大鼠新生心肌细胞单层时,治疗明显损害传导速度并减少连接蛋白43的量。DEHP处理也影响了细胞层的粘附和运动。提出的研究的主要目的是确认和了解DEHP对心肌影响的机制,并确定其临床相关性。该提案的目的1是剖析受DEHP影响的分子途径,使用基因组学和计算策略导致心脏电解偶联。临床相关浓度的DEHP将通过植入式渗透泵经肠外输送。将收集心室心脏组织并评估基因表达的改变。关键候选基因将使用功能验证分析进一步研究。该提案的目的2是确定体内暴露于DEHP是否会导致心功能障碍。DEHP将通过植入式渗透泵经肠外输送。在DEHP治疗前后,将进行超声心动图评估体内收缩力。切除心脏的光学成像将测量局部传导速度、钙瞬态和钙处理的变化。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The adverse cardiac effects of Di(2-ethylhexyl)phthalate and Bisphenol A.
  • DOI:
    10.1007/s12012-014-9258-y
  • 发表时间:
    2014-12
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
    Posnack, Nikki Gillum
  • 通讯作者:
    Posnack, Nikki Gillum
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nikki Gillum Posnack其他文献

Nikki Gillum Posnack的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nikki Gillum Posnack', 18)}}的其他基金

Off-label drugs in cardiology: evaluating age- and disease-appropriate therapies
心脏病学中的标签外药物:评估适合年龄和疾病的疗法
  • 批准号:
    10578746
  • 财政年份:
    2022
  • 资助金额:
    $ 4.71万
  • 项目类别:
Does Biocompatibility Contribute to Transfusion-Related Adverse Effects?
生物相容性是否会导致输血相关的不良反应?
  • 批准号:
    10321632
  • 财政年份:
    2018
  • 资助金额:
    $ 4.71万
  • 项目类别:
Does Biocompatibility Contribute to Transfusion-Related Adverse Effects?
生物相容性是否会导致输血相关的不良反应?
  • 批准号:
    10080105
  • 财政年份:
    2018
  • 资助金额:
    $ 4.71万
  • 项目类别:
The effect of endocrine disrupting chemicals on cardiac physiology
内分泌干​​扰化学物质对心脏生理的影响
  • 批准号:
    8618646
  • 财政年份:
    2014
  • 资助金额:
    $ 4.71万
  • 项目类别:
The effect of phthalates on the heart: molecular pathways and clinical relevance
邻苯二甲酸盐对心脏的影响:分子途径和临床相关性
  • 批准号:
    8003464
  • 财政年份:
    2011
  • 资助金额:
    $ 4.71万
  • 项目类别:
The effect of phthalates on the heart: molecular pathways and clinical relevance
邻苯二甲酸盐对心脏的影响:分子途径和临床相关性
  • 批准号:
    8207323
  • 财政年份:
    2011
  • 资助金额:
    $ 4.71万
  • 项目类别:

相似海外基金

How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y004841/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.71万
  • 项目类别:
    Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
  • 批准号:
    BB/Y001427/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.71万
  • 项目类别:
    Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y005414/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.71万
  • 项目类别:
    Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 4.71万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 4.71万
  • 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
  • 批准号:
    10821599
  • 财政年份:
    2023
  • 资助金额:
    $ 4.71万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10841832
  • 财政年份:
    2023
  • 资助金额:
    $ 4.71万
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    $ 4.71万
  • 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
  • 批准号:
    10741261
  • 财政年份:
    2022
  • 资助金额:
    $ 4.71万
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    $ 4.71万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了